WTO relaxes rule on drug patentsBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7322.1146b (Published 17 November 2001) Cite this as: BMJ 2001;323:1146
- Alex Vass
A declaration has been finalised at the World Trade Organization's meeting in Doha, Qatar, that will relax drug patents. Developing countries will now be able to seek a waiver on public health grounds from the organisation's strict rules—known as trade related aspects of intellectual property rights (TRIPS)—which guarantee drug patents for 20 years.
The wording of the agreement, which was still to be endorsed …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial